1,057.00
+17(+1.63%)
Currency In JPY
Sector
Healthcare
Industry
Medical - Devices
Employees
9245
First IPO Date
October 14, 2021
| Name | Title | Pay | Year Born |
| Ms. Kyoko Deguchi | President, Chief Executive Officer & Chairman | 0 | 1965 |
| Mr. Koichiro Sato | Senior EVice President, Chief Strategy Officer, Chief Operating Officer & Representative Director | 0 | 1973 |
| Kenichi Uchino | Corporate Officer | 0 | N/A |
| Hideaki Takahashi | Corporate Officer | 0 | N/A |
| Nobuaki Nakamura | Executive Corporate Officer and Head of Diagnostics & Life Sciences Domain | 0 | N/A |
| Ryuichi Hirashima | Senior Exec Corporate Officer, Chief Admin. Officer, Chief HR Officer & Chief Transformation Officer | 0 | N/A |
| Chikara Takauo | Corporate Officer | 0 | N/A |
| Kaiju Yamaguchi | Executive Corporate Officer & Chief Financial Officer | 0 | N/A |
| Steven Lynum | Corporate Officer | 0 | N/A |
| . Makise | IR & Corporate Communications | 0 | N/A |
PHC Holdings Corporation, through its subsidiaries, develops, manufactures, and sells medical devices, healthcare technology solutions, and life science products. The company offers blood glucose monitoring systems and other testing/analysis devices, as well as data linkage solutions; anatomical pathology solutions, such as instruments, microscope slides, and dyeing reagents; and equipment and services for various sample preservation and cell culture in the life sciences field. It also provides healthcare IT products in the field of medical information systems for clinics and healthcare insurance pharmacies. In addition, the company engages in clinical testing, diagnostic reagents, and drug development support businesses. The company was formerly known as Panasonic Healthcare Holdings Co., Ltd. and changed its name to PHC Holdings Corporation in April 2018. The company was founded in 2014 and is headquartered in Tokyo, Japan.
